Global Pediatric Vaccine Market 2019-2023 | Development of Vaccines for Unmet Medical Conditions to Boost Growth | Technavio

LONDON--(BUSINESS WIRE)-- The global pediatric vaccine market is expected to post a CAGR of over 7% during the period 2019-2023, according to the latest market research report by Technavio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190408005040/en/

The global pediatric vaccine market will post a CAGR of over 7% during the period 2019-2023. (Graphic: Business Wire)

The market contains a significant number of monotherapy and combination therapy-based vaccines that are currently under the late stages of development and are expected to get approved during the forecast period. For instance, Pertagen is a recombinant vaccine that is in the registration phase for immunization against pertussis in children aged 11 years and above. These vaccines possess a strong therapeutic potential for the prevention of a large number of infectious diseases and allergies in children. Hence, these products have a fair chance of entering the market during the forecast period. Furthermore, the recently approved vaccines for pediatric health are also driving market growth.

As per Technavio, the development of vaccines for unmet medical conditions will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global pediatric vaccine market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global pediatric vaccine market: Development of vaccines for unmet medical conditions

There are several unmet medical conditions such as HIV, malaria, tuberculosis, dengue, Ebola, H1N1, H5N1, cancer, and various allergic conditions. Significant advances in molecular biology and computational biology have made it possible to develop novel vaccines based on adjuvants, vectors, nucleic acids, and structure-based antigen design. Moreover, the leading manufacturers, in partnership with government bodies, have initiated the development of innovative vaccines owing to the availability of advanced procedures. Thus, such initiatives are expected to help the overall global pediatric vaccine market during the forecast period.

“The prevalence of infectious diseases is high in the pediatric population, as the immune system of children is not fully developed. Factors such as rising population as well as environmental and a few genetic factors are also contributing to the rapidly growing incidence of infectious diseases. Therefore, such factors are contributing to the growth of the market and encouraging the development of vaccines for unmet medical conditions,” says a senior analyst at Technavio.

Global pediatric vaccine market: Segmentation analysis

This market research report segments the global pediatric vaccine market by product (conjugate vaccines and others, live-attenuated vaccines, toxoid vaccines, inactivated vaccines) and geographical regions (North America, Europe, Asia, and ROW).

The North American region led the market in 2018, followed by Europe, Asia, and ROW respectively. However, during the forecast period, the Asian region is expected to register the highest incremental growth due to the increasing prevalence of infectious diseases, rising awareness of immunization, and growing healthcare expenditure on vaccination.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

• Market ecosystem
• Market characteristics
• Market segmentation analysis

Market Sizing

• Market definition
• Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

• Regional comparison
• Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190408005040/en/